MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 49 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,464,000 | -24.7% | 9,829,354 | -2.1% | 0.03% | -27.7% |
| Q2 2022 | $11,240,000 | -12.7% | 10,035,970 | -12.7% | 0.05% | -7.8% |
| Q1 2022 | $12,874,000 | -24.2% | 11,495,000 | +8.3% | 0.05% | -25.0% |
| Q4 2021 | $16,976,000 | -29.7% | 10,610,000 | +6.4% | 0.07% | -35.8% |
| Q3 2021 | $24,140,000 | -24.7% | 9,975,000 | -1.3% | 0.11% | -26.4% |
| Q2 2021 | $32,040,000 | +14.9% | 10,107,189 | +22.1% | 0.14% | +10.8% |
| Q1 2021 | $27,892,000 | +3643.9% | 8,276,500 | +2809.5% | 0.13% | +3150.0% |
| Q3 2020 | $745,000 | -35.1% | 284,469 | -24.1% | 0.00% | -42.9% |
| Q2 2020 | $1,148,000 | – | 375,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 10,366,120 | $8,926,000 | 0.45% |
| Clearline Capital LP | 3,957,135 | $3,407,000 | 0.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $6,342,000 | 0.26% |
| DAFNA Capital Management LLC | 1,096,513 | $944,000 | 0.25% |
| Privium Fund Management (UK) Ltd | 177,200 | $153,000 | 0.20% |
| Orbimed Advisors | 10,605,522 | $9,132,000 | 0.17% |
| Octagon Capital Advisors LP | 1,000,000 | $861,000 | 0.15% |
| Rock Springs Capital Management LP | 6,244,897 | $5,377,000 | 0.14% |
| Boxer Capital, LLC | 2,250,000 | $1,937,000 | 0.11% |
| Monaco Asset Management SAM | 186,656 | $161,000 | 0.06% |